New Pathways Clinic believes that patients will receive the best care if we work in tandem. Our PMHNP FNP Nora Finnegan is excited to make her 10 years of experience researching and providing Ketamine infusions for mental health available to your patients. Here is everything you need to know about Ketamine infusions and our referral process.
According to the CDC, the suicide rate in the USA has been steadily climbing since 1999. Suicide rates increased 33% between 1999 and 2019 and Suicide is now the 10th leading cause of death. It was responsible for more than 47,500 deaths in 2019.
Researchers have implicated the increase in depression and PTSD as causally related. Based on Nora Finnegan’s own research and experience at the Cleveland Clinic, she knows Ketamine is an invaluable tool to fight Treatment Resistant Depression, PTSD, and suicidal ideation. Other studies from respected institutions such as Columbia University, Yale, the National Institutes of Mental Health, and the Department of Defense, have demonstrated the efficacy of low-dose ketamine infusions to effectively treat these conditions:
Rapid Antidepressant Effects of Ketamine in Major Depression (National Institute of Mental Health)
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD) (Mt. Sinai and Department of Defense)
To begin treatment for your patient, we will need patient identifying information, as well as relevant medical records. To start this process, please fill out our Electronic Patient Referral or download and fax us the Referring Provider Form at 440-201-6400. Alternatively, you can always contact New Pathways Clinic at 440–973–8400 or email@example.com.
New Pathways Clinic provides evidence-based solutions for mental health, in accordance with the most recent science in the field. Our primary treatment of low-dose ketamine infusions is effective in relieving symptoms of Treatment Resistant Depression (TRD), PTSD, Bipolar Disorder, Anxiety, Neuropathic Pain, and Migraines.
Treatments are always given or supervised by PMHNP FNP Nora Finnegan, a published researcher on ketamine infusions, formerly with the Cleveland Clinic. Our patient’s evidence-based improvements are reported to you.
Our goal at New Pathways Clinic is to offer an adjunct therapy to the treatment you are already providing your patient. We want to collaborate with you to provide the most effective treatments available for your patients with Mental Health, Neuropathic Pain, or Migraine Disorders.
Our screening protocols include relevant mental health and pain scales, substance abuse screening, medical history assessment, pregnancy tests for women who are in child-bearing years, and blood tests when necessary. As part of this screening process, clarification of past psychotropic treatments and responses will be also be obtained.
Once clinical appropriateness is determined, ketamine infusion treatment will involve a sub-anesthetic and sub-dissociative dose given slowly, monitored by licensed professionals, and built around the best practices set forth by the American Psychiatric Association.